摘要
目的观察从肾论治方法拟定的强心合剂治疗充血性心力衰竭(CHF)的疗效。方法120例符合Framingham CHF诊断标准和中医辨证属肾虚病人,随机单盲分为强心合剂组、卡托普利组和地高辛组各40例,疗程3个月。结果强心合剂组、卡托普利组与地高辛组的总有效率分别为87.5%、90.0%与80.0%,经强心合剂治疗后病人肾虚症状总积分显著下降,而卡托普利组与地高辛组肾虚症状未见改善,两组分别与强心合剂组比较有统计学意义(P<0.01)。结论强心合剂能显著改善CHF病人的NYHA心功能分级和Lee心力衰竭评分,同时对CHF病人临床症状有改善。
Objective To observe the curative effect on treating congestive heart failure （ CHF ） with the strengthening heart prescription based on the kidney - treating theory. Methods One hundred and twenty patients （pts） with heart failure, differentiated as kidney deficiency, were randomly divide into three groups：The strengthening heart prescription group, the Captopril group and the I）igoxin group. Each group consisted of 40 pts,and the whole course lasted 3 months. Results The total effective rate in the strengthening heart prescription group, the Captopril group and the Digoxin group were 87.5 %, 90.0 % and 80.0 %, respectively. There were no significant differences between each groups. The score of kidney deficiency symptoms in the strengthening heart prescription group decreased remarkably（P 〈 0.01）. No improvement occurred in the Captopril group and the Digoxin group. Conclusion The strengthening heart prescription could improve the NYHA grade and Lee＇score significantly in pts with heart failure and increase the score of kidney deficiency symptoms remarkably. It could strengthen the contraction function of heart and restrain or reverse the development of heart remodeling.
出处
《中西医结合心脑血管病杂志》
2006年第1期1-3,共3页
Chinese Journal of Integrative Medicine on Cardio-Cerebrovascular Disease
关键词
从肾论治
强心合剂
心力衰竭
充血性
kidney treating therapy
strengthening heart prescription
congestive heart failure
